Acute myelocytic leukemia Acute lymphocytic leukemia Malignant lymphoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with these disease *Acute myelocytic leukemia *Acute lymphocytic leukemia *Mantle cell lymphoma *Diffuse large cell lymphoma with mutated both c-myc and bcl-2 *Burkitt's lymphoma Inpatients planned to undergo induction chemotherapy (Kyoto university hospital) 20 years old or over Patients being able to fill out questionnaire by themselves Patients with written informed consent
Exclusion criteria
Exclusion criteria: Patients who are not suitable for study inclusion based on the judgement of the primary phisician or the investigator Patients with difficulty in communication due to a mental disorder or cognitive impairment Patients with restrictions or contraindications to exercise due to a cardiovascular or respiratory disease Patients having gait disorder by a musculoskeletal problem or neurological disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference in physical activity pre- and post intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| The difference in physical function and activity of daily life between pre- and post intervention The executing rate of exercise The number of adverse events during observation period The difference in psychological function, fatigue and quality of life between pre- and post intervention | — |
Countries
Japan
Contacts
Kyoto university Laboratory of Clinical Locomotor Science, Human Health Sciences, Graduate School of Medicine